What does Palatin Technologies, Inc. do?
Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral small molecule PL7737 agonist in preclinical studies; long-acting peptide MC4R agonists; and…
What is Palatin Technologies, Inc.'s P/E and P/B ratio?
Palatin Technologies, Inc. has a P/E ratio of -1.9 and a P/B ratio of 0.93.
What is Palatin Technologies, Inc.'s debt-to-equity ratio?
Palatin Technologies, Inc. has a debt-to-equity ratio of 0.03.
How much does Palatin Technologies, Inc. owe compared with what it owns?
Palatin Technologies, Inc. owes $0.20 for every $1 it owns (balance sheet Mar 2026), which is low.
What is Palatin Technologies, Inc.'s Positivity rank?
Palatin Technologies, Inc. is ranked #1,324 of 6,774 companies globally and #277 of 4,000 in United States on PositoAI, with a Positivity Score of 22,937.
Does Palatin Technologies, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Palatin Technologies, Inc..
Where can I read the latest news about Palatin Technologies, Inc.?
Recent headlines about Palatin Technologies, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Palatin Technologies, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Palatin Technologies, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.